Psilocybin for Treatment-Resistant Depression

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions

Major Depressive DisorderAnhedoniaTreatment Resistant Depression

Interventions

DRUG

Psilocybin 25mg

25mg psilocybin capsule

DRUG

Placebo (active placebo)

1mg psilocybin capsule

Trial Locations (1)

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors

lead

University of Colorado, Denver

OTHER